ATE234366T1 - Reagenzzubereitung enthaltend magnetische partikel in form einer tablette - Google Patents

Reagenzzubereitung enthaltend magnetische partikel in form einer tablette

Info

Publication number
ATE234366T1
ATE234366T1 AT97109177T AT97109177T ATE234366T1 AT E234366 T1 ATE234366 T1 AT E234366T1 AT 97109177 T AT97109177 T AT 97109177T AT 97109177 T AT97109177 T AT 97109177T AT E234366 T1 ATE234366 T1 AT E234366T1
Authority
AT
Austria
Prior art keywords
magnetic particles
tablet
sample
preparation containing
containing magnetic
Prior art date
Application number
AT97109177T
Other languages
English (en)
Inventor
Herbert Dr Harttig
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Application granted granted Critical
Publication of ATE234366T1 publication Critical patent/ATE234366T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G01N33/567—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds utilising isolate of tissue or organ as binding agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326—Magnetic particles
    • G01N33/5434—Magnetic particles using magnetic particle immunoreagent carriers which constitute new materials per se
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Sampling And Sample Adjustment (AREA)
AT97109177T 1996-06-07 1997-06-06 Reagenzzubereitung enthaltend magnetische partikel in form einer tablette ATE234366T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19622885A DE19622885A1 (de) 1996-06-07 1996-06-07 Reagenzzubereitung enthaltend magnetische Partikel in Form einer Tablette

Publications (1)

Publication Number Publication Date
ATE234366T1 true ATE234366T1 (de) 2003-03-15

Family

ID=7796390

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97109177T ATE234366T1 (de) 1996-06-07 1997-06-06 Reagenzzubereitung enthaltend magnetische partikel in form einer tablette

Country Status (11)

Country Link
US (2) US6274386B1 (de)
EP (1) EP0811694B1 (de)
JP (1) JP3821541B2 (de)
KR (1) KR100260326B1 (de)
AT (1) ATE234366T1 (de)
AU (1) AU715803B2 (de)
CA (1) CA2206760C (de)
DE (2) DE19622885A1 (de)
DK (1) DK0811694T3 (de)
ES (1) ES2195053T3 (de)
IL (1) IL121008A (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19520398B4 (de) * 1995-06-08 2009-04-16 Roche Diagnostics Gmbh Magnetisches Pigment
KR100463475B1 (ko) 1995-06-08 2005-06-22 로셰 디아그노스틱스 게엠베하 자기성피그먼트
DE19743518A1 (de) * 1997-10-01 1999-04-15 Roche Diagnostics Gmbh Automatisierbare universell anwendbare Probenvorbereitungsmethode
US7569342B2 (en) 1997-12-10 2009-08-04 Sierra Molecular Corp. Removal of molecular assay interferences
US8337753B2 (en) 1998-05-01 2012-12-25 Gen-Probe Incorporated Temperature-controlled incubator having a receptacle mixing mechanism
ES2286750T3 (es) 1998-05-01 2007-12-01 Gen-Probe Incorporated Dispositivo para agitar el contenido liquido de un contenedor.
DE19836559A1 (de) 1998-08-12 2000-03-23 Antigen Gmbh Gefäß zur Entnahme von Blut
JP3561235B2 (ja) 1998-11-30 2004-09-02 ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング 核酸を精製するための磁性粒子
WO2001037291A1 (en) * 1999-11-17 2001-05-25 Roche Diagnostics Gmbh Magnetic glass particles, method for their preparation and uses thereof
US7005266B2 (en) * 2000-02-04 2006-02-28 Qiagen Gmbh Nucleic acid isolation from stool samples and other inhibitor-rich biological materials
DE10006662A1 (de) * 2000-02-15 2001-08-23 Antigen Produktions Gmbh Gefäß zur Nukleinsäureanalytik
CN1427743A (zh) * 2000-03-17 2003-07-02 H·隆德贝克有限公司 聚合物载体的剂型及其在有机化学合成中的用途和生产所说的剂型的方法
AU2001244085A1 (en) * 2000-03-17 2001-09-24 H. Lundbeck A/S Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form
US6602718B1 (en) 2000-11-08 2003-08-05 Becton, Dickinson And Company Method and device for collecting and stabilizing a biological sample
CA2474509C (en) * 2002-02-14 2012-01-31 Immunivest Corporation Methods and algorithms for cell enumeration in a low-cost cytometer
US9267167B2 (en) 2004-06-28 2016-02-23 Becton, Dickinson And Company Dissolvable films and methods including the same
JP2008504123A (ja) * 2004-06-28 2008-02-14 ホー・ルンドベック・アクティーゼルスカブ 化学物質をデリバリーするための多孔質物品
US8189899B2 (en) * 2004-07-30 2012-05-29 Veridex, Llc Methods and algorithms for cell enumeration in a low-cost cytometer
KR100850430B1 (ko) * 2006-12-11 2008-08-05 (주)바이오니아 입자상 물질을 사용하는 핵산 분리 방법 및 핵산 분리용조성물
EP2143496A1 (de) * 2008-07-09 2010-01-13 F. Hoffmann-Roche AG Lysereagenzformulierung mit magnetischen Partikeln in Tablettenform
WO2011026030A1 (en) * 2009-08-31 2011-03-03 Mbio Diagnostics Corporation Integrated sample preparation and analyte detection
TWI407994B (zh) 2009-10-22 2013-09-11 Ind Tech Res Inst 分離核酸的方法、試劑及套組
WO2019121842A1 (en) 2017-12-21 2019-06-27 F. Hoffmann-La Roche Ag Target enrichment by unidirectional dual probe primer extension
CN111801427B (zh) 2018-02-05 2023-12-05 豪夫迈·罗氏有限公司 用于单分子的单链环状dna模板的产生
US11898204B2 (en) 2018-03-02 2024-02-13 Roche Sequencing Solutions, Inc. Generation of single-stranded circular DNA templates for single molecule sequencing
JP7152599B2 (ja) 2018-09-21 2022-10-12 エフ．ホフマン－ラ ロシュ アーゲー 塩基配列決定のためのモジュール式およびコンビナトリアル核酸試料調製のためのシステムおよび方法
WO2021053008A1 (en) 2019-09-20 2021-03-25 F. Hoffmann-La Roche Ag Immune repertoire profiling by primer extension target enrichment
US12590328B2 (en) 2020-07-08 2026-03-31 Roche Sequencing Solutions, Inc. Targeted depletion of non-target library molecules using poison primers during target capture of next-generation sequencing libraries
US12378596B2 (en) 2020-12-03 2025-08-05 Roche Sequencing Solutions, Inc. Whole transcriptome analysis in single cells
JP2025522981A (ja) 2022-07-14 2025-07-17 エフ． ホフマン－ラ ロシュ アーゲー 一方向性デュアルプローブプライマー伸長によるバリアント対立遺伝子の濃縮
WO2025125266A1 (en) 2023-12-11 2025-06-19 Cube Biotech Gmbh Tablets containing fuctionalized agarose particles, method for producing them and use of the tablets
WO2025240460A2 (en) 2024-05-14 2025-11-20 Roche Molecular Systems, Inc. Assay for detection of mutations conferring resistance to treatment with an immunotherapeutic agent

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3981776A (en) * 1967-02-16 1976-09-21 Rolf Saxholm Magnetically responsive, biologically active substance and associated methods and apparatus
US4169804A (en) * 1976-08-19 1979-10-02 Minnesota Mining And Manufacturing Company Magnetically responsive composite microparticle
US4115534A (en) * 1976-08-19 1978-09-19 Minnesota Mining And Manufacturing Company In vitro diagnostic test
US4233169A (en) * 1979-04-13 1980-11-11 Corning Glass Works Porous magnetic glass structure
US4343901A (en) 1980-10-22 1982-08-10 Uop Inc. Magnetic support matrix for enzyme immobilization
US4483920A (en) * 1982-05-17 1984-11-20 Hahnemann University Immobilization of message RNA directly from cells onto filter material
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
US5746999A (en) * 1984-11-23 1998-05-05 Schering Aktiengesellschaft Magnetic particles for diagnostic purposes
US5597531A (en) * 1985-10-04 1997-01-28 Immunivest Corporation Resuspendable coated magnetic particles and stable magnetic particle suspensions
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
US5009994A (en) * 1986-03-24 1991-04-23 Em Diagnostic Systems, Inc. Particles containing mannitol suitable for tabletting into diagnostic reagents
US4712310A (en) * 1986-09-15 1987-12-15 E. I. Du Pont De Nemours And Company Co-spray technique
NO892244L (no) * 1988-06-06 1989-12-07 Photest Diagnostics Inc Fremgangsmaate til immundiagnostisk bestemmelse.
US5512439A (en) * 1988-11-21 1996-04-30 Dynal As Oligonucleotide-linked magnetic particles and uses thereof
EP0446260B1 (de) * 1988-11-21 1994-03-02 Dynal A.S. Sonden aus nukleinsäuren
US5234809A (en) * 1989-03-23 1993-08-10 Akzo N.V. Process for isolating nucleic acid
JPH04323560A (ja) * 1991-04-22 1992-11-12 Nippon Telegr & Teleph Corp <Ntt> レーザ磁気免疫測定に用いられる磁性微粒子標識材料並びに検体調整方法
DE4406139A1 (de) * 1994-02-25 1995-08-31 Matthias Werner Magnetische Depotarzneimittel für die perorale Applikation mit verbesserter Resorption der Wirkstoffe
US5593824A (en) * 1994-09-02 1997-01-14 Pharmacia Biotech, Inc. Biological reagent spheres
DE19520398B4 (de) * 1995-06-08 2009-04-16 Roche Diagnostics Gmbh Magnetisches Pigment

Also Published As

Publication number Publication date
CA2206760C (en) 2003-08-19
JP3821541B2 (ja) 2006-09-13
IL121008A0 (en) 1997-11-20
KR980003584A (ko) 1998-03-30
DE19622885A1 (de) 1997-12-11
US6746874B2 (en) 2004-06-08
DE59709467D1 (de) 2003-04-17
ES2195053T3 (es) 2003-12-01
EP0811694B1 (de) 2003-03-12
CA2206760A1 (en) 1997-12-07
US20010046714A1 (en) 2001-11-29
IL121008A (en) 2001-08-08
EP0811694A2 (de) 1997-12-10
KR100260326B1 (ko) 2003-03-15
AU715803B2 (en) 2000-02-10
AU2370597A (en) 1997-12-11
US6274386B1 (en) 2001-08-14
EP0811694A3 (de) 1999-01-13
DK0811694T3 (da) 2003-07-14
JPH1062422A (ja) 1998-03-06

Similar Documents

Publication Publication Date Title
DE59709467D1 (de) Reagenzzubereitung enthaltend magnetische Partikel in Form einer Tablette
AU6892994A (en) Composition for preventing or treating a T cell mediated pathology or unregulated T cell clonal replication comprising anti-idiotypic antibodies
AU641860B2 (en) Fluorosilicone compounds and compositions for adhesive release liners
AU642324B2 (en) Fluorescent compound, complex, reagent, and specific binding assay employing said reagent
EP0319294A3 (en) Improved membrane assay using focused sample application
AU7575291A (en) Process and composition for performing dna assays
AU3045392A (en) Specimen containing block for use in the preparation of multi-specimen slides for immunohistologic procedures
IS3966A (is) Aðferð til framleiðslu á lyfjablöndum sem innihalda nifedipine
PT72569A (en) Tetrazole derivatives process for the preparation thereof and anti-ulcer composition containing the same
EP0457214A3 (en) Method and reagent composition for the determination of alanine aminotransferase and hbsag antigen in the same biological specimen
AU5100090A (en) Fluorophore-labeled cryopreserved cells for use as targets in cytotoxicity assays
FI100425B (fi) Kasetti yksiotesekoitushanaa varten
AU3502889A (en) Polymaleimide compounds and process for the preparation thereof
GB8900250D0 (en) Polymerisable composition
IL88502A0 (en) Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor and methods for the preparation thereof
EP0306680A3 (en) Monoclonal antibodies to anti-thrombin binding substance, and their uses
GB2211091B (en) Polyester-based composition for the controlled release of medicinal substances
IL105349A0 (en) Pharmaceutical compositions containing beta-carbolines,methods for the preparation thereof and compounds for use in the preparation thereof
HUP0100542A3 (en) Progestogen and antiprogestogen containing kit, process for its preparation and use of the compounds for the preparation of contraseptives
HU903644D0 (en) Assays using albumin-tetrazolium interaction
AU2573695A (en) Process for the preparation of magnetic particles used in biological analyses
AU1547388A (en) Foundry binder compositions containing resorcinol and uses thereof
AU1881788A (en) Chemical compounds and compositions
KR930003870Y1 (en) Stopper of lever
ZA968020B (en) Novel composition containing an acid labile omeprazole and process for its preparation.